Evidence map›Paper›PMID 37875008›Full record

ArticleEuropean journal of public health2024

European value-based healthcare benchmarking: moving from theory to practice.

Borja García-Lorenzo, Ania Gorostiza, Itxaso Alayo, Susana Castelo Zas, Patricia Cobos Baena, Inés Gallego Camiña, Begoña Izaguirre Narbaiza, Gaizka Mallabiabarrena, Iker Ustarroz-Aguirre, Alina Rigabert and 24 more

Registry-linked trialAbstract read
In one paragraph

Article in European journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04960735 (Value-based Healthcare for Outcomes in Breast and Lung Cancer in Europe), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04960735 nacompletednot on this map

Value-based Healthcare for Outcomes in Breast and Lung Cancer in Europe

TypeinterventionalSponsorBiosistemak Institute for Health Systems ResearchRan2019 to 2023Enrolled1,007ConditionsBreast Cancer, Lung CancerArmsVOICE intervention
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Borja García-LorenzoBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.ORCID 0000-0002-6546-4186
Ania GorostizaBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.
Itxaso AlayoBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.
Susana Castelo ZasOsakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Innovation and Quality Assistant Service, Barakaldo-Bizkaia, Spain.
Patricia Cobos BaenaOsakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Mammary Pathology Service, Barakaldo-Bizkaia, Spain.
Inés Gallego CamiñaOsakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Innovation and Quality Assistant Service, Barakaldo-Bizkaia, Spain.
Begoña Izaguirre NarbaizaOsakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Analytical Accounting, Economic and Financial Directorate, Barakaldo, Spain.
Gaizka MallabiabarrenaOsakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Mammary Pathology Service, Barakaldo-Bizkaia, Spain.
Iker Ustarroz-AguirreOsakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Economic Evaluation Unit, Economic and Financial Directorate, Barakaldo, Spain.
Alina RigabertFundación Andaluza Beturia para la Investigación en Salud (FABIS), Huelva, Spain.
William BalziIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Roberta MaltoniIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Ilaria MassaIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Isabel Álvarez LópezOsakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.
Sara Arévalo LoberaOsakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.
Mónica EstebanOsakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Economic Resource Service, Donostia, Gipuzkoa, Spain.
Marta Fernández CallejaOsakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Mamary Pathology Service, Donostia, Gipuzkoa, Spain.
Jenifer Gómez MediavillaOsakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.
Manuela FernándezOsakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Economic Resource Service, Donostia, Gipuzkoa, Spain.
Manuel Del Oro HitarGynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
María Del Carmen Ortega TorresGynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
María Consuelo Sanz FerrandezGynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Luís Manso SánchezHospital Universitario 12 de Octubre, Madrid, Spain.
Pablo Serrano BalazoteHospital Universitario 12 de Octubre, Madrid, Spain.
Carolina Varela RodríguezHospital Universitario 12 de Octubre, Madrid, Spain.
Mario CamponeInstitut de Cancérologie de l'Ouest, Angers-Nantes, France.ORCID 0000-0002-5196-5908
Sophie Le LannInstitut de Cancérologie de l'Ouest, Angers-Nantes, France.
Piet VercauterDepartment of Pulmonary Medicine, Onze-Lieve-Vrouw Hospital, Aalst, Belgium.
Kurt TournoyDepartment of Pulmonary Medicine, Onze-Lieve-Vrouw Hospital, Aalst, Belgium.
Marina BorgesInstituto Português de Oncologia do Porto, Portugal.
Ana Sofía OliveiraInstituto Português de Oncologia do Porto, Portugal.
Marta SoaresInstituto Português de Oncologia do Porto, Portugal.
Ane FullaondoBiosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.
VOICE Study Group

Funding

Kronikgune InstituteThe VOICE Project, or 'Value-Based Healthcare for Outcomes in Breast and Lung Cancer in Europe', coordinated by the Kronikgune Institute, has the collaboration of Roche Farma, SA and Roche Diagnostics SLUValue-Based Healthcare for Outcomes in Breast and Lung Cancer in Europe
6 · The paper itself

Abstract

backgroundValue-based healthcare (VBHC) is a conceptual framework to improve the value of healthcare by health, care-process and economic outcomes. Benchmarking should provide useful information to identify best practices and therefore a good instrument to improve quality across healthcare organizations. This paper aims to provide a proof-of-concept of the feasibility of an international VBHC benchmarking in breast cancer, with the ultimate aim of being used to share best practices with a data-driven approach among healthcare organizations from different health systems.

methodsIn the VOICE community-a European healthcare centre cluster intending to address VBHC from theory to practice-information on patient-reported, clinical-related, care-process-related and economic-related outcomes were collected. Patient archetypes were identified using clustering techniques and an indicator set following a modified Delphi was defined. Benchmarking was performed using regression models controlling for patient archetypes and socio-demographic characteristics.

resultsSix hundred and ninety patients from six healthcare centres were included. A set of 50 health, care-process and economic indicators was distilled for benchmarking. Statistically significant differences across sites have been found in most health outcomes, half of the care-process indicators, and all economic indicators, allowing for identifying the best and worst performers.

conclusionsTo the best of our knowledge, this is the first international experience providing evidence to be used with VBHC benchmarking intention. Differences in indicators across healthcare centres should be used to identify best practices and improve healthcare quality following further research. Applied methods might help to move forward with VBHC benchmarking in other medical conditions.

Indexed as

BenchmarkingQuality of Health CareDelivery of Health CareHumans

Identifiers

PMID37875008
PMCPMC10843953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.